Brief: Astria Therapeutics Announces FDA Clearance Of IND Application For STAR-0310

Astria Therapeutics

10/12/2024 13:02

Dec 10 (Reuters) - Astria Therapeutics  ATXS.O :
    * ASTRIA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND
APPLICATION
FOR STAR-0310, A MONOCLONAL ANTIBODY OX40 ANTAGONIST FOR THE
TREATMENT OF ATOPIC DERMATITIS
    * ASTRIA THERAPEUTICS INC: PHASE 1A TRIAL OF STAR-0310 IN
HEALTHY
VOLUNTEERS EXPECTED TO INITIATE IN Q1 2025
    * ASTRIA THERAPEUTICS INC: EARLY PROOF-OF-CONCEPT RESULTS
EXPECTED
IN Q3 2025

Source text:  ID:nBw3gg0WFa 
Further company coverage:  ATXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))